This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Marinus A. Paul Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Craanen, M. E. Articles by Smit, E. F. Search for Related Content PubMed PubMed Citation Articles by Craanen, M. E. Articles by Smit, E. F. Related Collections Lung - cancer

Endoscopic ultrasound guided fine-needle aspiration and ¹⁸FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer

^a Department of Gastroenterology, VU University Medical Center, P.O.Box 7057, 1007MB, Amsterdam, The Netherlands
^b Department of Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
^c Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands
^d Department of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands

*Corresponding author. Tel.: +31-20-4440613; fax: +31-20-4440554.

E-mail address: me.craanen{at}vumc.nl (M.E. Craanen).

The accuracy of mediastinal staging is of paramount importance in the management of patients with non-small cell lung cancer (NSCLC) to select only those patients who might benefit from upfront resection or multimodality treatment. Although CT is the imaging technique of first choice, its performance characteristics have led to an increased use of both EUS-FNA and ¹⁸FDG-PET to improve (mediastinal) staging. In view of the relatively few studies employing both techniques simultaneously, we evaluated 20 consecutive patients (median age 70 years, range 48–83 years) with NSCLC in whom CT suggested N2 and/or N3 involvement. The sensitivity, specificity, PPV and NPV of EUS-FNA and ¹⁸FDG-PET was 86%, 100%, 100%, 90%, and 100%, 89%, 88% and 100%, respectively. EUS-FNA confirmed the absence of malignancy in all patients with a negative ¹⁸FDG-PET scan. Similarly, in the PET-positive patients, EUS-FNA confirmed malignancy in seven out of nine (78%) sites. Unnecessary surgery was prevented in six out of 16 patients otherwise considered as surgical candidates (37%). We conclude that both EUS-FNA and ¹⁸FDG-PET have excellent operating characteristics. However, initial ¹⁸FDG-PET findings should guide the complementary use of EUS-FNA to define treatment options and to prevent unnecessary surgery in selected patients.

Key Words: Endoscopic ultrasound; Fine-needle aspiration; Non-small cell lung cancer; Positron emission tomography; Staging